Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000170995 | SCV000223558 | uncertain significance | not provided | 2019-09-18 | criteria provided, single submitter | clinical testing | Has been reported in one individual with LQTS; however this individual also harbored a pathogenic variant in a second cardiac gene related to LQTS (Burns et al., 2016); Also reported as a variant of uncertain significant in a adult male with sudden cardiac arrest and no prior cardiac phenotype; additional information, such segregation or functional studies were not specified in this report (Asatryan et al., 2019); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27920829, 30975432, 31737537) |
Blueprint Genetics | RCV000208475 | SCV000263988 | uncertain significance | Ventricular fibrillation | 2015-05-22 | criteria provided, single submitter | clinical testing | |
Center For Human Genetics And Laboratory Diagnostics, |
RCV000496264 | SCV000588150 | uncertain significance | Andersen Tawil syndrome | 2017-03-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000816436 | SCV000956945 | uncertain significance | Andersen Tawil syndrome; Short QT syndrome type 3 | 2023-08-28 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 325 of the KCNJ2 protein (p.Arg325Cys). This variant is present in population databases (rs202067116, gnomAD 0.02%). This missense change has been observed in individual(s) with arrhythmogenic disorders and/or long QT syndrome (PMID: 27920829, 30975432, 31737537). ClinVar contains an entry for this variant (Variation ID: 190821). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNJ2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002372065 | SCV002692753 | benign | Cardiovascular phenotype | 2022-09-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |